GE Medical Systems has made its first commercial installation of Senographe 2000D, the company’s full-field digital mammography system. The unit received the CE Mark for European regulatory clearance this spring (SCAN 3/17/99), and on Sept. 2
GE Medical Systems has made its first commercial installation of Senographe 2000D, the companys full-field digital mammography system. The unit received the CE Mark for European regulatory clearance this spring (SCAN 3/17/99), and on Sept. 2 Senographe was placed at Charite Hospital in Berlin. The Milwaukee-based firm plans to install more than 50 Senographes outside the U.S. by the end of the year.
Senographe 2000Ds digital detector is based on amorphous silicon flat-panel detectors manufactured in the companys plant in Santa Clara, CA, a joint venture between GE and EG&G Amorphous Silicon (SCAN 9/3/97) The detectors are then shipped to France, where they are incorporated into Senographe systems built at the companys x-ray and mammography factory in Buc.
Can Contrast-Enhanced Mammography be a Viable Screening Alternative to Breast MRI?
June 17th 2025While the addition of contrast-enhanced mammography (CEM) to digital breast tomosynthesis (DBT) led to over a 13 percent increase in false positive cases, researchers also noted over double the cancer yield per 1,000 women in comparison to DBT alone.
Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization
June 2nd 2025Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.
Emerging AI Mammography Model May Enhance Clarity for Initial BI-RADS 3 and 4 Classifications
May 21st 2025In a study involving over 12,000 Asian women, researchers found that an artificial intelligence (AI) model converted over 83 percent of false positives in patients with initial BI-RADS 3 and 4 assessments into benign BI-RADS categories.